tiprankstipranks
Trending News
More News >
Magnera (MAGN)
NYSE:MAGN
US Market

Magnera (MAGN) Earnings Dates, Call Summary & Reports

Compare
156 Followers

Earnings Data

Report Date
May 13, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.09
Last Year’s EPS
-1.15
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Feb 04, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a mix of operational challenges (regional softness in Europe, competitive import pressure in South America, a small Americas EBITDA decline, and weather-related disruptions) but emphasized several positive fundamentals: solid liquidity and cash generation, active debt reduction, on-track Project CORE and synergy realization, targeted innovation launches (PFAS-free healthcare protection, battery materials, Kamisoft), and reaffirmed guidance for ~9% adjusted EBITDA growth in 2026. Management expressed confidence in margin expansion, portfolio optimization, and disciplined capital allocation while acknowledging near-term headwinds.
Company Guidance
Management reiterated FY2026 targets of adjusted EBITDA growth of 9% while assuming flattish volumes overall (Q1 sales were $792M and adj. EBITDA $93M), calling out Americas organic volume growth of 2% in Q1 and Europe guide of about -3%; key drivers include $25M of synergy realization in 2026 (part of a $55M ultimate synergy target) plus Project CORE benefits of $15–20M, with Rest of World adj. EBITDA up 9% to $35M; liquidity and cash priorities include ~$550M of available liquidity, free cash flow of $97M over the last four quarters (FCF midpoint for FY26 roughly $100M, ~18% yield), a plan to repay about $100M of debt in the year (already repaid $27M), a targeted 3.0x leverage ratio, and planned FY26 assumptions of ~$395M midpoint EBITDA working through ~$135M interest, ~$80M integration/taxes and ~$80M CapEx.
Quarterly Sales
Net sales of $792 million in Q1 FY2026, driven by strength across consumer solutions despite regional headwinds.
Adjusted EBITDA and Guidance
Adjusted EBITDA of $93 million for the quarter (flat year-over-year on a constant currency basis). Management reaffirmed full-year 2026 adjusted EBITDA guidance targeting ~9% growth.
Rest of World Earnings Improvement
Rest of World adjusted EBITDA increased 9% year-over-year to $35 million, reflecting disciplined cost management and synergy realization despite revenue declines in Europe.
Americas Volume Growth
Americas delivered 2% organic volume growth in the quarter, led by wipes and adult end markets (wipes benefited from elevated flu season demand).
Project CORE and Synergy Progress
Project CORE transformation tracking as planned; expected benefit in the range of $15–$20 million from CORE initiatives. Management expects $25 million of synergy realization in 2026 toward a $55 million total synergy target.
Strong Cash Generation and Liquidity
Free cash flow of $97 million over the last four quarters (approximate free cash flow yield ~18% based on market cap). Available liquidity of about $550 million at quarter-end.
Debt Reduction and Capital Allocation
Repaid $27 million of debt in the quarter and expects to repay approximately $100 million over the fiscal year; disciplined capital allocation and deleveraging target of ~3x leverage ratio.
Notable Product and Technology Innovations
Launched PFAS-free barrier protection for healthcare applications, advanced battery materials candidate for government grant, and expanded Kamisoft (softness platform) with $15 million sales last year and mid-single-digit growth into 2026; innovation margins expected above the corporate average (~11%), often mid-teens to 20%+.
Portfolio and Commercial Wins
Strong performance in premium private-label baby and disinfectant wipes, gains from branded Geca Tape in energy and cable applications, and infrastructure-driven growth in Europe from utility and data-cable spending.

Magnera (MAGN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MAGN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 2026
2026 (Q2)
0.09 / -
-1.15
Feb 04, 2026
2026 (Q1)
0.10 / >-0.01
-1.6999.64% (+1.68)
Nov 20, 2025
2025 (Q4)
-0.08 / -0.06
-4.36298.69% (+4.30)
Aug 06, 2025
2025 (Q3)
0.03 / -0.51
-4.66889.07% (+4.16)
May 07, 2025
2025 (Q2)
0.14 / -1.15
-7.5884.83% (+6.43)
Feb 06, 2025
2025 (Q1)
- / -1.69
-2.49632.29% (+0.81)
Oct 30, 2024
2024 (Q3)
- / -4.36
-2.99-45.89% (-1.37)
Aug 08, 2024
2024 (Q2)
- / -4.67
-5.8520.21% (+1.18)
May 09, 2024
2024 (Q1)
- / -7.58
-1.69-348.52% (-5.89)
Feb 22, 2024
2023 (Q4)
- / -0.52
-2.0875.00% (+1.56)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MAGN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 04, 2026
$14.20$14.96+5.35%
Nov 20, 2025
$10.18$11.54+13.36%
Aug 06, 2025
$12.16$11.49-5.51%
May 07, 2025
$15.17$12.43-18.06%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Magnera (MAGN) report earnings?
Magnera (MAGN) is schdueled to report earning on May 13, 2026, TBA (Confirmed).
    What is Magnera (MAGN) earnings time?
    Magnera (MAGN) earnings time is at May 13, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MAGN EPS forecast?
          MAGN EPS forecast for the fiscal quarter 2026 (Q2) is 0.09.